The CREB Coactivator TORC2 Functions as a Calcium- and cAMP-Sensitive Coincidence Detector  by Screaton, Robert A. et al.
Cell, Vol. 119, 61–74, October 1, 2004, Copyright 2004 by Cell Press
The CREB Coactivator TORC2 Functions as a
Calcium- and cAMP-Sensitive Coincidence Detector
Feeding also stimulates the release of certain gut hor-
mones such as glucagon-like peptide-1 (GLP-1) into the
circulation. These hormones enhance the effects of glu-
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cAMP and calcium pathways trigger CREB Ser133Elevations in circulating glucose and gut hormones
phosphorylation and target gene activation via the Ser/during feeding promote pancreatic islet cell viability
Thr kinases PKA and CaMKIV, respectively (Mayr andin part via the calcium- and cAMP-dependent activa-
Montminy, 2001). Ser 133 phosphorylation, in turn, stim-tion of the transcription factor CREB. Here, we de-
ulates target gene expression via recruitment of the co-scribe a signaling module that mediates the syner-
activator paralogs CBP and p300. CREB and CBP/p300gistic effects of these pathways on cellular gene
interact through well-defined domains called KID andexpression by stimulating the dephosphorylation and
KIX, respectively (Radhakrishnan et al., 1997). The abilitynuclear entry of TORC2, a CREB coactivator. This
of cAMP and calcium signals to converge at the levelmodule consists of the calcium-regulated phospha-
of CREB Ser133 phosphorylation provides a plausibletase calcineurin and the Ser/Thr kinase SIK2, both of
mechanism to explain how CREB mediates the coopera-which associate with TORC2. Under resting condi-
tivity between these pathways in electrically excitabletions, TORC2 is sequestered in the cytoplasm via a
cells.
phosphorylation-dependent interaction with 14-3-3
Recent studies showing that calcium signals destabi-
proteins. Triggering of the calcium and cAMP second
lize the CREB:CBP complex through secondary phos-
messenger pathways by glucose and gut hormones phorylation events on CREB, however, have challenged
disrupts TORC2:14-3-3 complexes via complementary this model and argued for the involvement of additional
effects on TORC2 dephosphorylation; calcium influx CREB coactivators (Kornhauser et al., 2002). Indeed, a
increases calcineurin activity, whereas cAMP inhibits potential role for the CREB DNA binding/dimerization
SIK2 kinase activity. Our results illustrate how a phos- domain (bZIP) in mediating transcriptional responses
phatase/kinase module connects two signaling path- to both calcium influx and cAMP has emerged from
ways in response to nutrient and hormonal cues. previous studies with GAL4-CREB fusion proteins
(Sheng et al., 1991). In that case, the bZIP appeared to
Introduction contribute significantly to induction of CREB activity in
response to membrane depolarizing signals, implicating
Elevations in blood glucose levels during feeding stimu- this domain in mediating the association of CREB with
late insulin release and islet cell gene expression in  a calcium-regulated coactivator.
cells through a specialized pathway that requires mito- In a recent screen to identify novel modulators of
chondrial glucose oxidation and ATP production (Hinke CREB activity, we and others characterized a family
et al., 2004). The ensuing closure of ATP-sensitive KATP of CREB coactivators called transducers of regulated
channels triggers  cell depolarization and calcium in- CREB activity (TORCs) (Conkright et al., 2003a; Iour-
flux through voltage-gated L-type calcium channels. genko et al., 2003). The three TORC family members
share an N-terminal coiled-coil domain that associates
with the CREB bZIP domain. The importance of CREB*Correspondence: mr-mb002@pop.med.osaka-u.ac.jp (H.T.);
in mediating cooperativity between cAMP and calciummontminy@salk.edu (M.M.)
4 These authors contributed equally to this work. second messengers in islet cells prompted us to ad-
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dress the regulatory contributions of TORC toward this respectively. Exposure to FSK stimulated the CREB:
CBP interaction 20-fold by this assay, but KCl had noprocess. Our studies illustrate a mechanism by which
calcium and cAMP pathways converge on TORC in islet effect (Figure 1E). Costimulation with both FSK and KCl
promoted complex formation at levels comparable tocells to regulate cellular gene expression in response
to nutrient and hormonal cues. FSK alone, arguing against a role for the CREB:CBP
complex in mediating the synergism between cAMP and
calcium pathways.Results
Having observed that cAMP and calcium do not pro-
mote CREB:CBP complex formation cooperatively, weThe CREB bZIP Domain Mediates Cooperativity
tested the role of the CREB bZIP domain, which hasbetween cAMP and Calcium Signals
been previously implicated in this process (Sheng et al.,We examined the effects of glucose and the gut hor-
1991). In transient assays of HIT cells, KCl and FSKmone GLP-1 on CREB target gene expression in MIN6
stimulated the activity of a full-length GAL4 CREB (aainsulinoma cells. Treatment with high glucose or the
1–341) construct cooperatively, and these effects wereGLP-1 analog exendin-4 stimulated expression of the
blocked by treatment with CsA (Figure 1F). By contrast,cAMP-responsive NR4A2 gene (Conkright et al., 2003b)
a GAL4-CREB bZIP (aa 1–283) protein lacking the5- and 3-fold individually and 20-fold in combination
C-terminal bZIP domain (aa 284–341) was far less re-(Figure 1A). Exposure to nifedipine, a potent L-type cal-
sponsive to both stimuli as well as to inhibition by CsA,cium channel antagonist, blocked induction of NR4A2
underscoring the involvement of the bZIP domain in thisby glucose, demonstrating the importance of calcium
context (Figure 1F).influx for these effects (Figure 1B). The calcium-acti-
The importance of the bZIP domain for GAL4-CREBvated Ser/Thr phosphatase calcineurin/PP2B (Cn) ap-
activation by KCl and FSK could reflect either recruit-peared to be critical for cooperativity between glucose
ment of a cofactor or dimerization of the bZIP with en-and exendin-4, as treatment with the Cn inhibitor cyclo-
dogenous CREB proteins. To differentiate betweensporine A (CsA) blocked induction of NR4A2 mRNA in
these two possibilities, we performed knockdown stud-response to both stimuli (Figure 1B).
ies. In control experiments, CREB siRNAs reduced cellu-Based on the ability of glucose to activate L-type
lar CREB protein levels to near-undetectable levels andcalcium channels, we used depolarizing concentrations
blocked the induction of a transfected EVX1 reporter byof KCl (45 mM) to mimic these effects in HIT insulinoma
FSK (see Supplemental Figure S2 on the Cell web site).cells. Similarly, we employed forskolin (FSK), an adenyl
Despite their effects on endogenous CREB levels andcyclase agonist, in place of exendin-4 because of its
activity, CREB siRNAs had no effect on the induction ofability to enhance  cell function via the cAMP pathway
the GAL4-bZIP protein by FSK in HEK293T cells (Figure(Hinke et al., 2004). When added to cultures of HIT cells
2A) or on the activation of a full-length RNAi-insensitiveindividually, KCl and FSK stimulated the CREB-depen-
GAL4-CREB polypeptide by FSK and KCl in HIT cellsdent EVX1 promoter 5- and 13-fold, respectively. In com-
(Supplemental Figure S3). These results argue against abination, they induced reporter activity synergistically
significant regulatory contribution of endogenous CREB(80-fold, Figure 1C). Similar to its inhibitory effects on
on transcriptional activation via the bZIP domain.NR4A2 induction by glucose and exendin-4, CsA also
blocked cooperativity between KCl and FSK (Figure 1C).
Consistent with the involvement of CREB in this process, Role of TORC2 in cAMP and Calcium Signaling
The recent characterization of TORCs, a family of CREBmutation of the CRE element on the EVX1 promoter
disrupted responses to both KCl and FSK (Conkright coactivators that binds to the CREB bZIP domain (Con-
kright et al., 2003a), led us to hypothesize that theseet al., 2003b) (see Supplemental Figure S1 at http://
www.cell.com/cgi/content/full/119/1/61/DC1/). proteins mediate the synergistic effects of cAMP and
calcium signals on target gene expression. We per-The ability of both calcium influx and cAMP to promote
Ser133 phosphorylation of CREB prompted us to test formed knockdown studies using siRNAs against TORC2
since this protein is expressed most abundantly in insu-whether activation of the two pathways leads to cooper-
ative changes in Ser133 phosphorylation and recruit- linoma and HEK293T cells relative to the other family
members (TORC1 and TORC3, data not shown). Indeed,ment of the coactivator paralogs CBP and p300. When
added to HIT cells in combination, KCl and FSK had no addition of TORC2 siRNAs nearly eliminated the induc-
tion of GAL4-bZIP activity by FSK in HEK293T cellsgreater effect on phospho-CREB levels relative to either
stimulus alone (Figure 1D). Moreover, exposure to CsA (Figure 2A). TORC2 knockdown also reduced the effects
of glucose and exendin-4 on EVX1 reporter activity indid not alter CREB Ser133 phosphorylation in response
to either stimulus, despite the ability of CsA to block MIN6 insulinoma cells, demonstrating the importance
of TORC2 in these contexts (Figure 2B). The inhibitorythe cooperative effects of KCl and FSK on CREB activity
(Schwaninger et al., 1995) (Figure 1D). effect of TORC2 knockdown on CREB activity appears
specific because overexpression of an RNAi-insensitiveAlthough calcium and cAMP pathways do not syner-
gize at the level of CREB Ser133 phosphorylation, they TORC2 construct rescued EVX1 reporter induction by
FSK (Supplemental Figure S4).could exert cooperative effects on the CREB:CBP inter-
action by modifying CBP (Impey et al., 2002) or a novel Based on the importance of TORC2 for bZIP-depen-
dent activation, we examined whether overexpressioncomponent of this pathway. To test this notion, we per-
formed mammalian two-hybrid assays in HIT cells using of TORC2 was sufficient to potentiate CREB target gene
expression in response to cAMP and calcium influx. ByGAL4-KID and KIX-VP16 expression vectors, which con-
tain the relevant interaction domains for CREB and CBP, contrast with its modest effects in resting HIT cells,
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Figure 1. cAMP and Calcium Pathways Stimulate CREB Activity Cooperatively via the CREB bZIP Domain
(A) Q-PCR analysis of NR4A2 mRNA levels in MIN6 cells exposed to glucose (GLU), exendin-4 (EX), or vehicle (CON).
(B) Effect of calcium channel antagonist (nifedipine; NIF) and calcineurin antagonist (cyclosporine A; CsA) on NR4A2 mRNA levels in MIN6
cells treated with GLU and EX as indicated.
(C) Transient assay of HIT cells transfected with the CREB-dependent EVX1 luciferase reporter. Treatment with KCl and forskolin (FSK) or
DMSO (CON) indicated. Effect of CsA or vehicle (VEH) shown.
(D) Western blot of phospho (Ser133) CREB levels in HIT cells treated with KCl and/or FSK for 30 min. Effect of CsA shown.
(E) Effect of calcium and cAMP agonists on CREB:CBP complex formation. (Top) Schematic of CREB; Q1 and Q2, glutamine rich domains;
KID, kinase inducible domain; bZIP, basic region/leucine zipper domain. Amino acid endpoints indicated. (Bottom) Two-hybrid assay of HIT
cells transfected with GAL4-KID and KIX-VP16 effector plasmids plus GAL4 luciferase reporter. Treatment with FSK and KCl indicated.
(F) Effect of KCl, FSK, and CsA on activity of full-length GAL4-CREB and truncated GAL4-CREB bZIP (aa 1–283) lacking the bZIP domain
in HIT cells.
TORC2 stimulated EVX1 reporter activity 60-fold in re- found to be defective in TORC2 binding by GST pull-
down and gel mobility shift assays (Figures 2E and 2F).sponse to FSK and 6-fold following exposure to KCl
(Figure 2C). Cotreatment with FSK and KCl enhanced Furthermore, TORC2 was unable to potentiate the activ-
ity of Arg314Ala mutant compared to wild-type CREBTORC2 activity more than 300-fold, and this cooperativ-
ity was blocked by pretreatment with CsA (Figure 2C). in transient assays with an EVX1 reporter (Supplemental
Figure S6). The Arg314Ala mutation in CREB affectedCREB was required for TORC2 potentiation, as siRNA-
mediated knockdown of CREB eliminated these effects neither dimerization nor DNA binding properties of the
CREB bZIP domain, indicating that loss of TORC2 po-in transient assays with an EVX1 reporter (Figure 2D).
To determine whether the CREB:TORC complex is tentiation reflects a direct effect on formation of the
TORC:CREB complex and not on CREB occupancynecessary for cooperativity between cAMP and calcium
signals, we screened for mutations in the bZIP domain (Supplemental Figure S7). The association of TORC with
the bZIP domain also had no effect on binding site selec-that block this interaction. Based on the sensitivity of
the CREB:TORC complex to high-salt conditions (data tivity; in gel shift assays using the CREB-related CREM
protein, CREM:TORC complexes were formed only onnot shown), we tested whether Ala mutations at charged
residues within the CREB leucine zipper would disrupt CRE sites as opposed to lower-affinity AP-1 sites (Sup-
plemental Figure S8). These experiments suggest thatthis association. Of five mutants tested, Arg314Ala was
Cell
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Figure 2. TORC2 Mediates Cooperative Effects of cAMP and Calcium Signals on CREB Activation
(A) Transient assay of HEK293T cells transfected with GAL4 bZIP (aa 271–341) vector plus GAL4 luciferase reporter. Effect of CREB, TORC2,
or nonsilencing (NS) siRNAs on GAL4-bZIP activity in cells treated with FSK or vehicle (VEH) shown.
(B) Effect of TORC2 or nonsilencing (NS) shRNA plasmids on induction of cotransfected EVX1 luciferase reporter by glucose and exendin-4
in MIN6 cells. (Inset) Western blot assay showing effect of TORC2 versus nonsilencing (NS) siRNA on TORC2 protein levels by Western blot assay.
(C) Transient assay showing effect of TORC2 or empty vector on EVX1 reporter activity in HIT cells exposed to FSK and/or KCl. Pretreatment
with CsA or vehicle (VEH) as indicated.
(D) Transient assay of HEK293T cells transfected with TORC2 or empty vector. Cotransfection with either nonsilencing (NS) or CREB siRNA
indicated. Luciferase activity from cotransfected EVX1 reporter shown. Treatment with FSK or vehicle (VEH) indicated. (Inset) Reduction of
CREB protein levels in CREB versus NS or TORC2 RNAi treated cells verified by Western blot assay with anti-CREB antiserum.
(E) GST pull-down assay of 35S-labeled TORC1 with wild-type and mutant GST CREB bZIP (aa 271–341) proteins. Effect of individual bZIP
Ca2 and cAMP Signaling via the CREB:TORC Pathway
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the effect of TORC on CREB target gene expression green fluorescent protein (GFP), we identified a nuclear
localizing sequence (NLS) at aa 56–144 of TORC2 andreflects its ability to recruit the transcriptional machinery
rather than to alter CREB binding to the promoter. two nuclear export sequences (NES1 and NES2) within
aa 145–320 (Figure 3C, top; Supplemental Figure S10).To test the regulatory contributions of TORC and CBP
toward CREB activation, we used GAL4-CREB constructs Both NLS and NES motifs were conserved within the
three TORC family members, and mutagenesis of indi-containing point mutations that disrupt either CREB:CBP
(Ser133Ala:M1) or CREB:TORC (Arg314Ala:M2) com- vidual leucines in NES1 and NES2 promoted nuclear
accumulation of TORCs 1 and 2 (data not shown). Con-plexes. By contrast with the wild-type GAL4-CREB poly-
peptide, M1 and M2 mutants were far less responsive sistent with the presence of both NLS and NES motifs,
TORCs appear to cycle in and out of the nucleus underto KCl or FSK individually in HIT cells (Figure 2G). The
CBP interaction-defective M1 polypeptide was induced resting conditions; treatment of ATYB1 cells with the
exportin inhibitor leptomycin B promoted nuclear accu-4-fold in response to KCl and FSK, and these effects
were blocked by CsA. By contrast, the TORC interac- mulation of TORC2 (Figure 3C).
By contrast with TORCs 1 and 2, TORC3 was nucleartion-defective M2 mutant was completely unresponsive
to cotreatment with KCl and FSK, suggesting that localized under basal conditions (Figure 3D) and was
far more active in potentiating CREB activity relative toTORC2 is primarily responsible for the synergistic ef-
fects of calcium and cAMP on cellular gene expression. TORC2 (data not shown). An analysis of the relevant
export domains between TORC family members re-Based on the importance of the CREB:TORC2 interac-
tion for transcriptional induction, calcium and cAMP ag- vealed that TORC3 contains a Tyr in place of Phe at aa
282 within NES1, which would be predicted to disruptonists would be predicted to enhance recruitment of
TORC2 to CREB-regulated genes. In chromatin immu- export activity (Figure 3D, top). Mutagenesis of Tyr282
in TORC3 to Phe, as in TORCs 1 and 2, led to cytoplasmicnoprecipitation (ChIP) assays of HIT insulinoma cells,
TORC2 was largely absent from the NR4A2 promoter retention of the protein (Figure 3D, bottom) and re-
pressed basal TORC3 activity (data not shown). Indeed,under resting conditions (Figure 3A, left). Although FSK
or KCl alone had only modest effects on TORC recruit- exposure to FSK triggered nuclear translocation of the
Tyr282Phe TORC3 mutant, supporting the involvementment (1.0- and 1.7-fold, respectively), cotreatment with
FSK and KCl induced TORC2 occupancy 4.6-fold. More- of NES1 in signal-dependent shuttling (Figure 3D,
bottom).over, the cooperative recruitment of TORC2 to the
NR4A2 promoter was completely blocked by CsA. In-
deed, the profile for TORC occupancy paralleled the TORC2 Phosphorylation Is Regulated by cAMP
and Calcium Influxchanges in NR4A2 mRNA levels with each treatment
(Figure 3A, right), supporting the notion that TORC2 me- The subcellular localization of certain activators, such
as NFAT and FOXO family members, is regulated bydiates the cooperative effects of cAMP and calcium on
target gene activation. signal-dependent phosphorylation or dephosphoryla-
tion (Brunet et al., 1999; Chow and Davis, 2000). To test
whether TORC2 localization is similarly modulated, weNuclear Entry of TORC2 Is Regulated by cAMP
and Calcium Influx compared the mobilities of TORC2 proteins isolated
from nuclear and cytoplasmic fractions. OverexpressedIn the course of experiments to determine TORC cellular
localization, we noticed that TORC2 protein was largely Flag-TORC2 migrated as an 85 kDa doublet in cyto-
plasmic fractions but as a single faster-migrating spe-confined to the cytoplasm in MIN6 and HIT cells under
resting conditions (Figure 3B). Individually, glucose and cies in nuclear extracts (Figure 4A, top left). The slower-
migrating TORC2 band in cytoplasmic extracts likelyexendin-4 had no effect on TORC2 localization; in com-
bination, however, they promoted redistribution of represents phosphorylated TORC2, as treatment with
calf intestinal alkaline phosphatase (CIP) collapsed thisTORC2 to the nucleus (Figure 3B, top). Exposure to both
KCl and FSK also promoted TORC2 nuclear entry; in all doublet into the single faster-migrating species (Figure
4A, top right).cases, pretreatment with CsA potently disrupted this
process (Figure 3B, top and bottom). The accumulation of unphosphorylated TORC2 in nu-
clear fractions suggests that calcium and cAMP path-To determine the mechanism by which TORC2 subcel-
lular localization is regulated, we characterized relevant ways stimulate TORC2 nuclear entry by triggering its
dephosphorylation. Indeed, exposure of HIT cells to KClnuclear import and export signals using a human fibro-
blast line (ATYB1) in which cytoplasmic and nuclear and FSK in combination promoted extensive dephos-
phorylation of endogenous TORC2 as determined bytargeting could be readily assessed. In contrast to the
electrically excitable MIN6 and HIT cells, FSK treatment Western blot analysis with anti-TORC2 antiserum (Fig-
ure 4A, bottom). Moreover, treatment with CsA blockedof ATYB1 cells was sufficient to trigger nuclear translo-
cation of TORC2 (Figure 3C, left). Using cellular fluores- TORC2 dephosphorylation, implicating the involvement
of calcineurin in this process (Figure 4A, bottom).cence assays on truncated TORC polypeptides fused to
mutations on TORC binding shown. CBB, Coomassie gel showing input levels of bZIP proteins.
(F) Gel shift assay of wild-type and Arg314Ala mutant recombinant CREB bZIP (aa 271–341) peptides using 32P-labeled CRE oligo. Addition
of recombinant TORC1 (aa 1–129) to reactions indicated.
(G) Transient assay of HIT cells expressing wild-type (wt) or mutant GAL4-CREB proteins defective in either CBP (M1: Ser133Ala) or TORC
(M2: Arg314Ala) binding. Effect of FSK, KCl, FSKKCl, and CsA or VEH on GAL4 luciferase reporter activity shown.
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Figure 3. Cooperative Effects of cAMP and Calcium Pathways on TORC Activity
(A) (Top and bottom) ChIP assays of the CREB-regulated NR4A2 gene in HIT cells exposed to KCl, FSK, and CsA as indicated. Levels of
NR4A2 promoter recovered from individual IPs (CREB, phospho [Ser133] CREB, and TORC) measured by PCR amplification with 32P-labeled
primers. (Right) Q-PCR analysis of NR4A2 mRNA levels in HIT cells treated with FSK, KCl, and CsA or vehicle (VEH) indicated.
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Figure 4. cAMP and Calcium Influx Promote Dephosphorylation of TORC2 at Ser171
(A) (Top left) Western blot (WB) of nuclear (N) and cytoplasmic (C) fractions from HEK293T cells transfected with Flag-TORC2. (Right) Effect
of calf intestinal alkaline phosphatase (CIP) treatment on mobility of IPed TORC2. (Bottom) Western blot with TORC2 antiserum showing
effect of FSK plus KCl treatment on endogenous TORC2 dephosphorylation in HIT cells. Treatment with CsA indicated.
(B) Mass spectrometry (MS) of sites on TORC2 phosphorylated in vivo. Phosphopeptides recovered from Flag-TORC2 IPs identified by MS/
MS analysis. Phosphoacceptor Sers in bold.
(C) (Top) 2D phosphotryptic mapping of 32P-labeled Flag-TORC2 recovered from IPs of HIT cells treated with FSK, KCl, and CsA as indicated.
Maps (1000 cpm/map) of wild-type, truncated (aa 1–240), and mutated (S171A, S369A) TORC2 proteins shown. Major tryptic spots labeled
1–5. Arrowheads point to spots regulated by FSK and KClCsA. (Bottom right) Phosphoamino acid analysis of 32P-labeled TORC2 recovered
from HIT cells as above. Positions of phosphorylated Ser, Thr, and Tyr indicated.
(D) Western blot of extracts from HIT cells transfected with a Flag-TORC2 vector and treated with DMSO (CON), KCl, FSK, and CsA as
indicated and probed with  phospho (Ser171) TORC2 antiserum. Total amounts of Flag-tagged TORC2 for each condition (F-TORC2)
determined by blotting with -Flag antiserum. (Right) Graph showing relative levels of phospho (Ser171) TORC2, by densitometry, after
normalizing for Flag-TORC2 levels.
We used tandem mass spectrometric (MS) analysis was phosphorylated exclusively on serine by phosphoa-
mino acid analysis (Figure 4C, bottom right). 2D trypticto identify phosphorylation sites on TORC2 that dictate
its subcellular localization. Twelve independent phos- maps of 32P-labeled TORC2 revealed five major spots
(1–5, Figure 4C), four of which (1, 2, 3, and 5) werephorylated serine residues on TORC2 were identified by
analysis of Flag-TORC2 immunoprecipitates from assigned to the C-terminal 350 residues of TORC2; only
spot 4 was detected in 2D maps of a truncated TORC2HEK293T cells, the majority of these (seven of 12) map-
ping to a central region (aa 300–500) in TORC2 (Fig- polypeptide extending from aa 1 to aa 240 (Figure 4C).
Indeed, spot 4 corresponds to the primary TORC2 phos-ure 4B).
To identify phosphorylation sites on TORC2 that are phorylation site, accounting for over half of 32P incorpo-
rated by the full-length protein in resting cells.regulated by cAMP or calcium influx, we performed two-
dimensional (2D) tryptic mapping experiments in HIT Following treatment with FSK, the intensity of spot
4 was specifically diminished, suggesting that cAMPcells. Consistent with MS studies, 32P-labeled TORC2
(B) Immunofluorescence (IF) assay showing effect of glucose, exendin-4, and CsA (top) or FSK, KCl, and CsA (bottom) on cellular localization
of Flag-TORC2 (F-TORC2) in MIN6 (top) and HIT (bottom) insulinoma cells. Counterstaining with DAPI shown to visualize nuclei.
(C) (Top) Schematic showing relative positions of NLS and NES motifs in TORC2 as determined by IF assay with truncated TORC proteins
(Supplemental Figure S10). (Left) IF analysis of Flag-TORC2 in human ATYB1 fibroblasts treated with FSK or vehicle for 30 min. (Right) Effect
of exportin inhibitor leptomycin B (LMB) on localization of TORC2 in transfected ATYB1 fibroblasts. DAPI staining shown.
(D) (Top) Amino acid sequence alignment for NES1 motif (aa 271–287 in TORC2) in TORC family members relative to consensus NES motif.
Tyr282 in TORC3 highlighted. (Bottom) Effect of Tyr282 to Phe mutagenesis in NES1 on TORC3 localization in control and FSK treated ATYB1
cells. Staining of wild-type TORC3 in untreated cells shown. DAPI staining included.
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regulates TORC2 phosphorylation at one principal site 14-3-3 proteins bind directly to multiple phosphorylated
regions on TORC2.(Figure 4C). Although exposure to KCl had minor effects
by 2D mapping, treatment with KCl plus CsA specifically In view of their ability to promote TORC2 dephosphor-
ylation at Ser171 and other sites, KCl and FSK mightenhanced spots 2 and 5. These results support the no-
tion that cAMP and calcium pathways regulate dephos- be expected to modulate the TORC2:14-3-3 interaction.
Indeed, exposure to either stimulus reduced TORC2phorylation of TORC2 at distinct sites.
We assigned relevant phosphoacceptor sites that cor- binding to 14-3-3 by Far Western blot assay, and co-
treatment with CsA reversed these effects (Figure 5B).respond to cAMP- and calcium-regulated spots by per-
forming mutational studies on phosphorylated serines These results support the idea that cAMP and calcium
influx individually disrupt the TORC:14-3-3 interactionidentified by MS. Although a number of substitutions
(Ser70Ala and Ser394Ala; data not shown) had no effect by promoting dephosphorylation of TORC2 at distinct
sites.on 2D maps of 32P-labeled TORC2, mutation of Ser171 to
Ala eliminated spot 4, and Ser369Ala mutation disrupted The ability of CsA to interfere with TORC2 dephos-
phorylation and liberation from 14-3-3 proteins led usspots 2 and 5 (Figure 4C). Spots 2 and 5 appear to
correspond to differentially phosphorylated forms of the to examine the role of Cn in regulating TORC2 activity.
Notably, Cn A and B subunits were recovered from im-same 19 kDa tryptic fragment (aa 243–428) of TORC2,
which contains 38 potential serine phosphoacceptors. munoprecipitates of Flag-TORC2 in MS studies, and we
confirmed these results in pull-down assays using full-Having identified Ser171 as a principal phosphoryla-
tion site on TORC2 that is dephosphorylated in response length 35S-labeled TORC2 with GST-CnA (aa 1–347) (Fig-
ure 5C). The Cn:TORC2 interaction also appears direct;to cAMP, we developed a phospho (Ser171)-specific
TORC2 antiserum. Consistent with 32P labeling studies, in Far Western blotting assays, a recombinant CnA poly-
peptide was found to bind efficiently to Flag-TORC2treatment with FSK reduced levels of phospho (Ser171)
TORC2 6-fold within 10 min (Figure 4D). Exposure to recovered from anti-Flag immunoprecipitates from HIT
cells (Figure 5D). By contrast with the TORC2:14-3-3KCl alone had a small effect (2-fold) on phospho (Ser171)
TORC2 levels, but costimulation with both FSK and KCl interaction, however, dephosphorylation of TORC2 with
CIP had no effect on CnA binding, indicating that thereduced amounts of phospho (Ser171) TORC2 coopera-
tively (12-fold). These results indicate that, although cal- TORC2:CnA complex is not modulated by phosphoryla-
tion (Figure 5D).cium and cAMP pathways promote dephosphorylation
at independent sites on TORC2, they converge on TORC2 contains three near-consensus PXIXIT motifs
(Cn1, PNVNQIG [aa 72–78]); Cn2, PNIILT [aa 615–620];Ser171 when activated together.
and Cn3, PGINIF [aa 248–253]), which have been shown
to mediate CnA binding in NFAT and other calcium-Phosphorylated TORCs Associate
regulated proteins (Hogan et al., 2003). Indeed, muta-with 14-3-3 Proteins
genesis of either Cn2 or Cn3 motifs in TORC2 reducedIn the course of MS studies on TORC2 phosphorylation,
binding of CnA to TORC2 by GST pull-down and Farwe detected 14-3-3 proteins in immunoprecipitates (IPs)
Western blotting assays, but Cn1 mutations had no ef-of TORC2. Notably, 14-3-3 proteins have been found to
fect (Figures 5C and 5D). Supporting a functional rolebind and sequester a number of regulatory proteins,
for Cn binding in TORC2 activation, the Cn3 mutantincluding CDC25A, Forkhead, and NFAT family mem-
TORC2 protein was 2.5-fold less responsive to KCl rela-bers, in a phosphorylation-dependent manner (Brunet
tive to wild-type TORC2 in HIT cells cotransfected withet al., 1999; Chen et al., 2003; Chow and Davis, 2000;
an EVX1 reporter (Figure 5E).Durocher et al., 2000). Confirming the results from MS
The importance of Ser171 as a major regulatory siteanalysis, endogenous 14-3-3 proteins were recovered
for dephosphorylation in response to FSK and KClfrom IPs of Flag-TORC2 prepared from HEK293T cells
prompted us to examine whether Ser171Ala mutagene-(Figure 5A, left). Given the importance of Ser171 as a
sis alters TORC2 activity in response to these stimuli.primary phosphorylation site on TORC2, we tested
Compared with the wild-type protein, Ser171Ala mutantwhether the Ser171Ala mutant polypeptide was also as-
TORC2 was 3-fold more active under basal conditionssociated with 14-3-3 in cells. By contrast with the levels
in HIT (Figure 5E) and HEK293T (Figure 5F) cells, andof 14-3-3 protein recovered from IPs of wild-type
treatment with KCl or FSK had only modest effects onTORC2, 14-3-3 proteins were only weakly detected in
Ser171Ala mutant TORC2 activity. These results supportIPs of Ser171Ala mutant TORC2. These results support
the notion that Ser171 is a key site for cooperative induc-the involvement of Ser171 in the TORC2:14-3-3 inter-
tion of TORC2 activity by cAMP and calcium signalingaction.
pathways.To further test the importance of TORC2 phosphoryla-
tion for complex formation with 14-3-3 protein, we used
Far Western blotting assays. A recombinant GST-14-3- TORC2 Associates with the Ser/Thr Kinase SIK2
Based on the extensive phosphorylation of TORC2 in3 polypeptide was found to bind phosphorylated TORC2
isolated from HIT cells under basal conditions but not quiescent cells, we speculated that an inhibitory Ser/
Thr kinase may interact with and sequester TORC2 inTORC2 dephosphorylated in vitro with CIP (Figure 5A,
right). Consistent with the importance of Ser171 as a the cytoplasm. Using in vitro kinase assays on TORC2
immunoprecipitates, we found that a Ser/Thr kinase ac-principal phosphorylation site on TORC2, mutation of
Ser171 to Ala substantially reduced complex formation tivity was associated with TORC2 in cytoplasmic (C) but
not nuclear (N) fractions of HEK293T cells (Figure 6A,with 14-3-3, although not to the same extent as CIP
treatment (Figure 5A, right). These results indicate that left). Indeed, the TORC2 kinase activity appeared to
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Figure 5. 14-3-3 Proteins Associate with Phosphorylated TORCs
(A) (Left) CoIP of wild-type and Ser171Ala mutant Flag-TORC2 with endogenous 14-3-3 proteins in HEK293T cells. IPed Flag-TORC2 and
CoIPed 14-3-3 proteins shown. Input levels of 14-3-3 proteins shown (bottom). (Right) Far Western blot assay of Flag-TORC2 IPs from HIT
cells expressing wild-type or Ser171Ala mutant Flag-TORC2. Blots were probed with recombinant GST-14-3-3 protein. Effect of TORC2
dephosphorylation by CIP on 14-3-3 binding shown. (Bottom right) (FLAG) Western blot assay showing recovery of TORC2 proteins from
-Flag IPs by Western blotting with -Flag antiserum.
(B) Effect of FSK, KCl, or vehicle (VEH) on 14-3-3 binding by Far Western blot assay of Flag-TORC2 IPs prepared from HIT cells. Effect of
CsA on 14-3-3 binding indicated. (Bottom) Recovery of Flag-TORC2 from each IP by Western blot with -Flag antiserum.
(C) Pull-down assay of GST-CnA (aa 1–347) with 35S-labeled wild-type and mutant TORC2 proteins as indicated. (Right) Input levels of wild-
type and mutant TORC2 proteins shown.
(D) Far Western blot assay of Flag IPs from HIT cells transfected with control vector or Flag-TORC2 vector and probed in parallel with either
recombinant GST-14-3-3 (top) or GST-CnA (bottom) proteins. Effect of TORC2 dephosphorylation by CIP on CnA and 14-3-3 binding shown.
Top bands in each lane represent full-length protein. Wild-type and mutant TORC2 proteins (Cn1a [aa 72–78], PNVNQIG/GNANQAA; Cn1b
[deletion of aa 56–144]; Cn2 [aa 615–620], PNIILT/GNAIAA; Cn3 [aa 248–257], PGINIFPSPD [aa 249–257 deleted]) indicated.
(E) Transient assay of HIT cells transfected with wild-type or mutant TORC2 expression vectors defective in either CnA binding (Cn3) or
phosphorylation (Ser171A). Luciferase activity from EVX1 reporter plasmid shown. Treatment with KCl and CsA indicated.
(F) Transient assay of HEK293T cells showing effect of wild-type and Ser171Ala mutant TORC2 expression vector or empty vector (CON) on
EVX1 reporter activity in cells treated with FSK or vehicle (VEH).
phosphorylate primarily one site corresponding to spot To determine the identity of the putative cAMP-regu-
lated TORC2 kinase, we performed MS studies on4 (Ser171) by 2D tryptic mapping (Figure 6A, right). More-
over, exposure to FSK potently inhibited the TORC- TORC2 immunoprecipitates prepared from HEK293T
cytoplasmic lysates. Among other potential kinasesassociated kinase activity by in vitro assay, providing
a potential mechanism to explain how cAMP inhibits identified by this analysis, we detected the salt-inducible
kinase 2 (SIK2), a member of the snf1 family of kinasesSer171 phosphorylation on TORC2.
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Figure 6. The Ser/Thr Kinase SIK2 Associ-
ates with and Phosphorylates TORC2
(A) In vitro kinase assays of endogenous
TORC (IP:TORC) and transfected Flag-
TORC2 (IP:FLAG) IPs prepared from nuclear
(N) or cytoplasmic (C) fractions of control and
FSK treated HEK293T cells as shown. 32P-
labeled TORC2 bands (left) and correspond-
ing TORC2 protein levels by Western blot
assay with -Flag antiserum (right) indicated.
(Right) 2D tryptic mapping of Flag-tagged
TORC2 IPed from HEK293T cells and phos-
phorylated with 32P-ATP by in vitro kinase
assay. Position of spot 4 (as shown in Figure
3) indicated.
(B) CoIP assay of HEK293T cells cotrans-
fected with expression vectors for SIK2, Flag-
TORC2, or empty vector. Western blot of SIK2
recovered from Flag IPs using anti-SIK2 anti-
serum shown.
(C) SIK2 phosphorylates TORC2 at Ser171.
In vitro kinase assay of wild-type and Ser171-
Ala GST TORC2 (aa 162–179) using purified
SIK2 as indicated. Effect of SIK2 on GST and
GST-syntide 2 containing an optimal SIK2
phosphorylation site shown. (Middle) West-
ern blot assay using phospho (Ser171)-spe-
cific TORC2 antiserum. (Bottom) Input levels
of individual GST proteins (CBB).
(D) SIK2 stimulates binding of 14-3-3 to
TORC2 at Ser171. Flag-TORC2 (aa 1–240) wt
or S171A mutant proteins were IPed from
HEK293T cells cotransfected with SIK2 plas-
mid or empty vector control. CoIPed 14-3-3
proteins (top), IPed TORC2 (1–240) proteins
(middle), and input levels of 14-3-3 from cell
lysates for each condition shown.
(E) Schematic of TORC2 showing position of
CREB Binding domain (CBD), nuclear local-
ization and export signals (NLS and NES), and
transactivation domain (TAD). In vivo phos-
phorylation sites, identified by mass spectro-
metric analysis, shown as circles. Binding
sites for 14-3-3 and CnA indicated. Site for
SIK2 phosphorylation (Ser171) indicated.
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previously found to inhibit transcription of cAMP- phorylation-defective (Ser587Ala) mutant SIK2, how-
ever, demonstrating the importance of SIK2 phosphory-responsive genes (Doi et al., 2002). We confirmed the
association between SIK2 and TORC2 in coimmuno- lation by PKA for TORC2 nuclear entry in response to
cAMP. The phosphorylation of TORC2 at Ser171 by SIK2precipitation (CoIP) assays of HEK293T cells cotrans-
fected with SIK2 and Flag-TORC2 expression vectors appears pivotal in this regard; TORC Ser171Ala mutant
protein was targeted to the nucleus of ATYB1 cells under(Figure 6B). Indeed, TORC2 mobility was noticeably re-
duced in cells coexpressing SIK2, consistent with the both basal and cAMP stimulated conditions (Figure 7C,
bottom). Taken together, these results indicate that theidea that this kinase directly phosphorylates TORC2
in vivo (Figure 6B). SIK2-mediated phosphorylation of TORC2 at a single
site (Ser171) favors sequestration of TORC2 and inhibi-Based on in vitro phosphorylation studies with poten-
tial SIK2 substrates, we deduced an optimal consensus tion of CREB activity in the basal state (Figure 7D).
motif for SIK2 phosphorylation (LXBS/TXSXXXL, where
B is a basic residue; Supplemental Table S1). Remark- Discussion
ably, TORC2 contains a single consensus site for SIK2
phosphorylation corresponding to Ser171 (aa 166–LNR- We have described a mechanism by which two second
TSSDSAL). Indeed, SIK2 was found to phosphorylate messenger pathways converge on CREB to regulate 
wild-type but not Ser171Ala mutant GST-TORC2162–179 cell gene expression in response to glucose and gut
in vitro (Figure 6C). SIK2 did not appear to phosphorylate hormones. The synergistic effects of these pathways on
other potential sites on TORC2, including Ser70 and cellular gene expression require the CREB bZIP domain,
Ser394 (data not shown), suggesting that Ser171 is the a region which has been found to contribute functionally
principal phosphoacceptor site for this kinase. to cAMP and calcium signaling in excitable cells (Bonni
Based on its ability to phosphorylate Ser171, SIK2 et al., 1995; Sheng et al., 1991). Indeed, the importance
would be expected to promote the association of TORC2 of the bZIP domain for target gene activation may ex-
with 14-3-3 proteins. Indeed, overexpression of SIK2 plain in part why CREB selectively homodimerizes with
strongly enhanced binding of Flag-TORC2 (aa 1–240) related family members (CREB1, ATF1, and CREM) and
protein to 14-3-3, and this effect was blocked by muta- not with other bZIP proteins (Newman and Keating,
tion of Ser171 to Ala (Figure 6D). Demonstrating the 2003). Taken together, these results extend the func-
direct role of phospho (Ser171) in 14-3-3 binding, SIK2 tional role of bZIP domains to include not only DNA
also stimulated the interaction of 14-3-3 proteins with binding and dimerization but also coactivator recruitment.
a wild-type but not Ser171Ala mutant TORC2 peptide TORC2 appears to fulfill a number of criteria as a
(aa 162–179) fused to GST (Supplemental Figure S11). coactivator that mediates cooperativity between cAMP
Taken together, these studies indicate that SIK2 and Cn and calcium signals in islet cells. First, TORC2 stimulates
associate with and regulate TORC2 phosphorylation as CREB activity through a bZIP domain interaction, and
well as its association with 14-3-3 proteins (Figure 6E). point mutants in CREB that disrupt this interaction also
block cooperativity between these pathways. Secondly,
cAMP and calcium signals act synergistically in promot-SIK2 Inhibits TORC2 Translocation
cAMP has been found to disrupt SIK2 activity via the ing TORC2 nuclear translocation and promoter recruit-
ment. Finally, loss of TORC2 expression in insulinomaPKA-mediated phosphorylation of SIK2 at Ser587 (Oka-
moto et al., 2004). Supporting this notion, exposure of cells inhibits the transcriptional response to glucose
and exendin.COS-7 cells to FSK increased phospho (Ser587) SIK2
levels by Western blot assay with a phospho (Ser587)- CBP and TORC enhance the expression of cAMP-
responsive genes by associating with distinct regionsspecific antiserum (Figure 7A). In keeping with its ability
to stimulate the TORC:14-3-3 interaction, wild-type SIK2 of CREB. Although both interactions are regulated by
phosphorylation, the mechanisms are very different.inhibited induction of an EVX1 reporter by FSK about
3-fold (Figure 7B). SIK2 kinase activity was required for CREB is constitutively targeted to the nucleus, for exam-
ple, and its phosphorylation at Ser133, along withinhibition, as overexpression of a kinase-inactive SIK2
mutant (K49M) had no such effect. Consistent with a role CREB:CBP complex formation, in response to inductive
signals is rate limited by nuclear entry of relevant Ser/Thrfor cAMP in regulating SIK2, the PKA phosphorylation-
defective SIK2 (Ser587Ala) mutant was more potent in kinases via passive diffusion, a comparatively inefficient
process. By contrast, TORC2 is cytoplasmic under rest-blocking EVX1 reporter activity in response to FSK (Fig-
ure 7B). ing conditions, undergoing rapid dephosphorylation and
nuclear translocation within minutes of stimulation. TheHaving seen that SIK2 enhances the TORC2:14-3-3
interaction via phosphorylation at Ser171, we reasoned cytoplasmic localization of TORC in resting cells may
thus provide improved coupling with early signalingthat SIK2 would correspondingly promote cytoplasmic
sequestration of TORC2. In immunocytochemical stud- events at the plasma membrane and insure that short-
lived signals are efficiently transmitted to the nucleus.ies of ATYB1 cells, Flag-TORC2 was localized to both
nuclear and cytoplasmic compartments under resting Under resting conditions, TORC2 is sequestered in
the cytoplasm through a phosphorylation-dependent in-conditions (Figure 7C). However, coexpression of SIK2
in these cells resulted in exclusive cytoplasmic localiza- teraction with 14-3-3 proteins. Calcium and cAMP ago-
nists were found to stimulate the dephosphorylation oftion of TORC2. Consistent with the ability of PKA to
disrupt SIK2 activity, treatment with FSK promoted TORC at distinct sites (Ser171 and Ser369). Although
both sites appear to participate in 14-3-3 binding, phos-TORC2 nuclear translocation in SIK2-expressing cells.
FSK had no such effect in cells expressing the phos- pho (Ser171) performs a dominant role. Indeed, binding
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Figure 7. SIK2 Phosphorylates and Sequesters TORC2 in the Cytoplasm under Basal Conditions
(A) Western blot of total and phospho (Ser587)-SIK2 levels in COS-7 cells transfected with wild-type and PKA phosphorylation defective
Ser587Ala mutant GST-SIK2 expression vector. Effect of FSK treatment shown.
(B) Transient assay of HEK293T cells showing effects of wild-type, PKA phosphorylation-defective (S587A), or kinase-inactive (K49M) SIK2
expression vectors relative to empty vector (CON) on activity from cotransfected EVX1 luciferase reporter in HEK293T cells treated with FSK
or vehicle (VEH).
(C) Effect of SIK2 on TORC2 subcellular localization. Immunofluorescence assay of ATYB1 cells transfected with Flag-TORC2 plus wild-type
or PKA phosphorylation defective SIK2 (Ser587Ala) constructs as indicated. DAPI staining shown below each panel. (Bottom) Cellular localization
of mutant Ser171Ala TORC2 polypeptide shown. Treatment with FSK or vehicle (CON) indicated.
(D) TORC2 mediates synergistic effects of calcium and cAMP pathways on CREB activation. TORC2 is sequestered in the cytoplasm under
basal conditions via a phosphorylation-dependent association with dimeric 14-3-3 proteins. Calcium and cAMP pathways trigger release from
14-3-3 proteins by activating a TORC2 phosphatase (Cn) and inhibiting a TORC2 kinase (SIK2), respectively. Dephosphorylated TORC2 migrates
into the nucleus and is recruited to the promoter via an interaction with the bZIP domain of CREB.
of ligands to 14-3-3 proteins is generally thought to in an altered conformation of the ligand. Based on its
proximity to the TORC2 NLS (aa 56–144), phosphory-occur initially at a high-affinity or gatekeeper site and
then at a weak secondary site (Yaffe, 2002), resulting lated Ser171 may promote TORC2 cytoplasmic localiza-
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Far Western, Western, IP, and GST Pull-Downtion by masking this motif from the nuclear import ma-
Rabbit pan-TORC (aa 1–42 of human TORC1), TORC2 (aa 454–607 ofchinery.
mouse TORC2), and phospho-Ser171 TORC2 (aa 161–181 of mouseIn quiescent cells, TORC2 is highly phosphorylated at
TORC2) antisera were generated as described (Conkright et al.,
Ser171 by SIK2, a member of the AMPK family of Ser/ 2003a). Chromatin IP, CoIP, and GST pull-downs were performed
Thr kinases. The kinase activity of SIK2 and other AMPK as described (Asahara et al., 2001; Conkright et al., 2003a). For Far
Western blotting assays, blots were probed with 0.1 M GST-14-family members requires prior phosphorylation at a con-
3-3  or GST-calcineurin A (aa 1–347). TORC:14-3-3 and TORC:CnAserved Thr in the T loop by the tumor suppressor protein
complexes were detected by Western blot assay with rabbit anti-LKB-1 (Carling, 2004). Germline mutations of LKB1 have
GST antiserum.been described in Peutz-Jehgers syndrome (PJS), an
autosomal dominant disorder characterized by intesti- Plasmids and RNAi
nal polyposis and increased frequency of certain gastro- Mutant TORC and CREB cDNAs were generated using standard
intestinal malignancies (Carling, 2004; Lizcano et al., cloning protocols. TORC2 shRNAi plasmid has been described
(Conkright et al., 2003a). siRNA duplexes against CREB and TORC22004; Shaw et al., 2004; Woods et al., 2003). Loss of
were from Qiagen.LKB-1 would be predicted to activate CREB target gene
expression by blocking SIK2-mediated phosphorylation
Transfectionsof TORC2 at Ser171. It will be of interest to determine
Cells were cotransfected with EVX-LUC or GAL4-LUC reporter plas-
to what extent the CREB:TORC pathway contributes to mid, RSV- gal and Flag-TORC, and/or SIK2 expression plasmids.
the etiology of PJS. For RNAi-mediated knockdown, extracts were harvested after 72
CsA was found to block CREB target gene activation hr. Luciferase values were normalized to -gal activity.
in islet cells by interfering with the dephosphorylation
Phosphorylation Assaysof TORC2 at Ser171. The use of CsA and FK506, a sec-
In Vivoond Cn inhibitor, for immunosuppressive therapy in or-
40 hr posttransfection, HIT cells were incubated with phosphate-gan transplant recipients is frequently associated with
free DMEM containing 10% dialyzed serum and 1 mCi of [32P]ortho-
development of  cell failure and diabetes (Al-Uzri et phosphate/ml. After 4–12 hr, cells were washed and harvested in
al., 2001; Filler et al., 2000). Based on their ability to boiling SDS or RIPA lysis buffer. Samples were immunoprecipitated
using anti-Flag agarose (Sigma) after preclearing with Staph A. Tryp-prevent TORC2 activation in response to glucose and
tic peptide mapping was performed as described (Hagiwara etincretin signaling, these inhibitors may promote islet cell
al., 1992).death by blocking CREB target gene activation through
In Vitrothis pathway. The development of specific SIK antago-
Flag-TORC2 and endogenous TORC immune complexes were
nists may improve islet cell function and offer useful washed with lysis buffer and subjected to kinase assays using 50
therapy for insulin-resistant individuals. Ci -ATP.
The effects of SIK2 and perhaps related AMPK family
Indirect Immunofluorescencemembers on cellular gene regulation by CREB are likely
Human ATYB1 fibroblasts, HIT, and MIN6 cells were fixed with 4%to extend to other electrically excitable tissues. Both
paraformaldehyde, permeabilized with 0.1% Triton X-100, andSIKs and TORCs are highly expressed in the brain, for
stained stepwise with Flag M2 antibody, donkey anti-mouse, or anti-
example, an area where CREB appears to function in rabbit Alexa 488- or Cy3-conjugated secondary antibody (Molecular
higher-order processes such as learning and memory. Probes, Eugene, OR; Jackson Immunochemicals), and mounted in
Targeted disruption of SIK and TORC genes in these and Vectashield with DAPI counterstain (Vector Labs).
other tissues will help to elucidate the cellular contexts in
Mass Spectrometrywhich this pathway mediates responses to extracellu-
TORC2 IPs were prepared (MacCoss et al., 2002), and peptide mix-lar signals.
tures were analyzed by MudPIT analysis (Link et al., 1999). Tandem
mass spectra were searched against the most recent versions of
Experimental Procedures the predicted rat, mouse, and human proteins, to which common
contaminants such as keratin and trypsin were added using a modi-
Chemicals fied version of the PEP_PROB algorithm. Search results were filtered
LMB and Exendin-4 (Sigma, Saint Louis, MO) were used at 10 ng/ml and grouped using DTASelect (Tabb et al., 2002). For phosphoryla-
and 10 nM, respectively. Nifedipine (10 M), cyclosporine A (CsA, tion analysis, a subset database was generated containing only
5 M), and okadaic acid (OA, 100 nM) were from Calbiochem (San TORC2. Phosphorylation sites that were matched by multiple tan-
Diego, CA). Cells were treated with forskolin at 10 M and with KCl dem mass spectra representing sequences of different molecular
at 45 mM. weights (from the nonspecific enzymes used in the digest) were
called matches.
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